Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (331-340 of 527) with videos related to

Pageof 53
Sort By:
Cancers|February 6, 2021
Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain MetastasesPetra A Mercea, Mario Mischkulnig, Barbara Kiesel, et al.
Cancer Treatment Reviews|January 1, 2026
Targeted therapies in optic pathway gliomasEdoardo Agosti, Pier Paolo Panciani, Giuseppe Lombardi, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2014
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapyMathilde Foedermayr, Miriam Sebesta, Margaretha Rudas, et al.
Journal of Clinical Medicine|May 2, 2020
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength EvaluationAriane Steindl, Johannes Leitner, Matthias Schwarz, et al.
Breast (Edinburgh, Scotland)|May 7, 2026
HER2-directed therapy is associated with an increased rate of cardiologic emergency department visits in real-world breast cancer patientsSandra Mayer, Anna Pfarrhofer, Sophie M Neubauer, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Cancer Treatment Reviews|December 21, 2024
Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850]Eugenia Cella, Alberto Bosio, Pasquale Persico, et al.
Frontiers in Oncology|July 18, 2020
Rare Primary Central Nervous System Tumors in Adults: An OverviewEnrico Franceschi, Didier Frappaz, Roberta Rudà, et al.
Neuro-Oncology|October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomasNina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Journal of Neurology|August 3, 2021
Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literatureAnnette Leibetseder, Johannes Leitner, Maximilian J Mair, et al.
Pageof 53

Showing results (331-340 of 527) with videos related to

Sort By:
Pageof 53
Cancers|February 6, 2021
Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain MetastasesPetra A Mercea, Mario Mischkulnig, Barbara Kiesel, et al.
Cancer Treatment Reviews|January 1, 2026
Targeted therapies in optic pathway gliomasEdoardo Agosti, Pier Paolo Panciani, Giuseppe Lombardi, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2014
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapyMathilde Foedermayr, Miriam Sebesta, Margaretha Rudas, et al.
Journal of Clinical Medicine|May 2, 2020
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength EvaluationAriane Steindl, Johannes Leitner, Matthias Schwarz, et al.
Breast (Edinburgh, Scotland)|May 7, 2026
HER2-directed therapy is associated with an increased rate of cardiologic emergency department visits in real-world breast cancer patientsSandra Mayer, Anna Pfarrhofer, Sophie M Neubauer, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Cancer Treatment Reviews|December 21, 2024
Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850]Eugenia Cella, Alberto Bosio, Pasquale Persico, et al.
Frontiers in Oncology|July 18, 2020
Rare Primary Central Nervous System Tumors in Adults: An OverviewEnrico Franceschi, Didier Frappaz, Roberta Rudà, et al.
Neuro-Oncology|October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomasNina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Journal of Neurology|August 3, 2021
Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literatureAnnette Leibetseder, Johannes Leitner, Maximilian J Mair, et al.
Pageof 53